Watson, C. and Calabretto, H. (2007) Comprehensive re- view of conventional and non-conventional methods of management of recurrent vulvovaginal candidiasis. Aust N Z J Obstet Gynaecol, 47(4), 262-272.
 González, G.M., et al. (2007) Therapeutic efficacy of posaconazole against isolates of Candida albicans with different susceptibilities to fluconazole in a vaginal mo- del. Medical Mycology, 45 (3), 221-224.
 Pfaller, M.A., et al. (2001) Vitro activities of posaconazole (Sch 56592) compared with those of itraconazole and Fluconazole against 3,685 clinical isolates of Candida spp. and Cryptococcus neoformans. Antimicrobial Agents and Chemotherapy, 45(10), 2862-2864.
 Smith, W.J., Drew, R.H. and Perfect, J.R. (2009) Posaconazole’s impact on prophylaxis and treatment of invasive fungal infections: an update. Expert Review of Anti- Infective Therapy, 7(2), 165-181.
 Hof, H. (2008) Is there a serious risk of resistance development to azoles among fungi due to the widespread use and long-term application of azole antifungals in medicine? Drug Resistance Updates, 11(1-2), 25-31.